<< New report on cardiac diagnostic medical device market | Medworxx Policy & Procedure Management System implemented at Premier Health Partners >>

Read in | English | Español

Minimally invasive procedures drive the global uro-gynecological surgical devices market

Published on November 18, 2009 at 7:50 AM · No Comments

Reportlinker.com announces that a new market research report is available in its catalogue.

Organ and Tissue Transplantation - A World Market Analysis

World uro-gynecological surgical devices market is driven by the growing acceptance of minimally invasive procedures as a convenient alternative option to hysterectomy. Despite the higher costs involved, patients are opting for advanced surgical procedures that are less painful and require shorter duration of hospitalization. The market is also riding on the numerous research and development activities that are aimed at providing advanced and improved products. Focus has now shifted towards the development of surgical procedures that enable faster recovery with no/less post-operative complications.

SOURCE Reportlinker

87e83b01-f14d-41fc-8d09-9617c044b246|0|.0

Posted in: Device / Technology News | Women's Health News

Tags: Bone, Bone Marrow, Brain, Cell, Education, Heart Transplantation, Hysterectomy, Implants, Organ Donation, Stem Cell, Transplant

Related posts

Researchers discover kibra protein controls sculpting of brain circuitryResearchers working with adult mice have discovered that learning and memory were profoundly affecte...
Double balloon enteroscopy safe and effective for detection of small intestine diseasesA large-scale data review by researchers in China of double balloon enteroscopy (DBE) over the last ...
Thalidomide analog shows promise against sickle cell diseaseA thalidomide analog is shaping up as a safe, worthy opponent of sickle cell disease, Georgia Health...
Kidney transplant proposal - younger patients greater successSoon kidney transplant recipients would be younger under a proposal being considered by the nation’s...
CaPre drug candidate effective in managing impaired glucose toleranceNeptune Technologies & Bioressources Inc. subsidiary Acasti Pharma Inc. reports preclinical results ...
Ambit Biosciences and Astellas Pharma to jointly develop and commercialize FLT3 kinase inhibitorsAmbit Biosciences Corporation and Astellas Pharma Inc. today announced that they have entered into a...
Defibrotide drug effective against hepatic veno-occlusive diseaseDefibrotide, a novel drug which modulates the response of blood vessels to injury, was markedly more...
Stem cells from hair follicles may help 'grow' new blood vesselsFor a rich source of stem cells to be engineered into new blood vessels or skin tissue, clinicians m...
Blood-incompatible infant heart transplants safe, may save more livesABO-incompatible heart transplantation (heart transplantation among non-compatible blood groups) can...
Australian bionic ear pioneer awarded science medalUniversity of Melbourne Laureate Professorial Fellow and bionic ear pioneer Professor Graeme Clark h...
Fibroid tumors affecting many American women lack a key protein helps hold tissues togetherFibroid tumors — the sometimes painful uterine growths affecting many American women — lack a key pr...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.